Yi-Tian Chen found that NIFK-AS1 silencing could inhibit the proliferation, colony formation, and migration of hepatocellular carcinoma cells and sensitize tumor cells to sorafenib via upregulation of OATP1B1 and OATP1B3 (Chen et al., 2021). The gene discussed is SLCO1B1; the disease is hepatocellular carcinoma.